Your browser doesn't support javascript.
loading
"Extended" A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk.
Ide, Akane; Babu, Sunanda R; Robles, David T; Wang, Tianbao; Erlich, Henry A; Bugawan, Teodorica L; Rewers, Marian; Fain, Pamela R; Eisenbarth, George S.
Afiliação
  • Ide A; Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave., Box B140, Denver, CO 80262, USA.
Diabetes ; 54(6): 1879-83, 2005 Jun.
Article em En | MEDLINE | ID: mdl-15919812
ABSTRACT
To evaluate potential differential diabetes risk of DR3 haplotypes we have evaluated class I alleles as well as two microsatellites previously associated with differential risk associated with DR3 haplotypes. We found that over one-third of patient DR3 chromosomes consisted of an extended DR3 haplotype, from DQ2 to D6S2223 (DQ2, DR3, D6S273-143, MIC-A5.1, HLA-B8, HLA-Cw7, HLA-A1, and D6S2223-177) with an identical extended haplotype in controls. The extended haplotype was present more frequently (35.1% of autoimmune-associated DR3 haplotypes, 39.4% of control DR3 haplotypes) than other haplotypes (no other haplotype >5% of DR3 haplotypes) and remarkably conserved, but it was not transmitted from parents to affected children more frequently than nonconserved DR3-bearing haplotypes. This suggests that if all alleles are truly identical for the major A1, B8, DR3 haplotype (between A1 and DR3), with different alleles on nonconserved haplotypes without differential diabetes risk, then in this region of the genome DR3-DQ2 may be the primary polymorphisms of common haplotypes contributing to diabetes risk.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antígeno HLA-A1 / Antígeno HLA-B8 / Antígeno HLA-DR3 / Predisposição Genética para Doença / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Antígeno HLA-A1 / Antígeno HLA-B8 / Antígeno HLA-DR3 / Predisposição Genética para Doença / Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2005 Tipo de documento: Article País de afiliação: Estados Unidos